Literature DB >> 4037016

Biologic and morphologic development of donated human ova recovered by nonsurgical uterine lavage.

J E Buster, M Bustillo, I A Rodi, S W Cohen, M Hamilton, J A Simon, I H Thorneycroft, J R Marshall.   

Abstract

Using uterine lavage performed 5 days after the luteinizing hormone peak, we collected 25 uterine ova from five fertile donors who had had a single, periovular artificial insemination. After examination, all recovered ova were transferred to recipient uteri and resulted in three intrauterine and one tubal pregnancy. Morphologic development ranged from degenerating single-cell ova to mature blastocysts. Ages of the ova at recovery ranged from 93.5 to 130.0 hours postovulation. Mean age of the five blastocysts, 109.1 hours, was not significantly different from the mean age of the 20 less mature ova, 108.1 hours. Neither the mean interval from insemination to recovery for blastocysts nor the mean interval from insemination to ovulation for blastocysts was significantly different from the mean intervals of the other ova. The five blastocysts resulted in intrauterine pregnancies in three recipients. There were no intrauterine pregnancies from the other 20 transfers (p less than 0.004). A transferred 12-cell ovum with degenerating blastomeres was associated with tubal pregnancy in the recipient. The large variability in the state of intrauterine ova observed in the relatively fixed postovulatory interval of this study appears to be due to differences in viability and maturation, not differences in ovum age. Maturational state of the ova at the time of transfer appears to be a significant determinant of the likelihood of ensuring pregnancy.

Entities:  

Mesh:

Year:  1985        PMID: 4037016     DOI: 10.1016/0002-9378(85)90116-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  22 in total

Review 1.  Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure?

Authors:  David A Clark
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

Review 2.  Endometrial cultures and their application to new reproductive technologies: a look ahead.

Authors:  A Birkenfeld; D Navot
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

Review 3.  Controversies and opinions in embryo culture: two- to four-cell transfer vs blastocyst.

Authors:  V N Bolton
Journal:  J Assist Reprod Genet       Date:  1992-12       Impact factor: 3.412

Review 4.  Epigenetic influences on oocyte developmental competence: perifollicular vascularity and intrafollicular oxygen.

Authors:  J Van Blerkom
Journal:  J Assist Reprod Genet       Date:  1998-05       Impact factor: 3.412

5.  Early embryo mortality in natural human reproduction: What the data say.

Authors:  Gavin E Jarvis
Journal:  F1000Res       Date:  2016-11-25

6.  Gap junctions, compaction, and development.

Authors:  S Lee
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-12

7.  Primate preimplantation embryo is a target for relaxin during early pregnancy.

Authors:  Catherine A Vandevoort; Namdori R Mtango; Keith E Latham; Dennis R Stewart
Journal:  Fertil Steril       Date:  2011-06-08       Impact factor: 7.329

8.  Development of spare human preimplantation embryos in vitro: an analysis of the correlations among gross morphology, cleavage rates, and development to the blastocyst.

Authors:  V N Bolton; S M Hawes; C T Taylor; J H Parsons
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-02

9.  Preimplantation development following in vitro fertilization of mouse oocytes: effects of timing of superovulation and preincubation in vitro.

Authors:  D H Edgar; K M Whalley; J A Mills
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-04

Review 10.  Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences.

Authors:  Brittany L Daughtry; Shawn L Chavez
Journal:  Cell Tissue Res       Date:  2015-11-21       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.